Catheter-based closure of aortic and mitral paravalvular leaks: existing techniques and new frontiers
TA Joseph, CE Lane, EA Fender, CJ Zack… - Expert review of …, 2018 - Taylor & Francis
Introduction: Significant paravalvular leak (PVL) complicates between 6% and 15% of valve
replacements and can result in heart failure and hemolysis. Paravalvular leak can be …
replacements and can result in heart failure and hemolysis. Paravalvular leak can be …
Catheter-based closure of paravalvular leak
GW Reed, EM Tuzcu, SR Kapadia… - Expert review of …, 2014 - Taylor & Francis
Paravalvular leak (PVL) is a serious complication from surgical and percutaneous valve
replacement procedures. The most common manifestations include congestive heart failure …
replacement procedures. The most common manifestations include congestive heart failure …
Percutaneous management of paravalvular leaks
JP Giblett, LK Williams, N Moorjani, PA Calvert - Heart, 2022 - heart.bmj.com
Paravalvular leak (PVL) is a challenging complication of valve replacement surgery that can
cause heart failure and haemolysis. Surgical repair is the traditional treatment for severe …
cause heart failure and haemolysis. Surgical repair is the traditional treatment for severe …
Paravalvular leaks—from diagnosis to management
S Bernard, E Yucel - Current treatment options in cardiovascular medicine, 2019 - Springer
Purpose of review As the number of surgical and transcatheter valve replacements continue
to increase in the aging population, so does the incidence of paravalvular leak (PVL). Given …
to increase in the aging population, so does the incidence of paravalvular leak (PVL). Given …
[HTML][HTML] Long-term outcomes of catheter-based intervention for clinically significant paravalvular leak: Long-term outcomes of percutaneous PVL closure
Background In most centres, clinically significant percutaneous paravalvular leak (PVL)
closure following valve replacement surgery is reserved for those considered high-risk for …
closure following valve replacement surgery is reserved for those considered high-risk for …
Transcatheter closure of paravalvular leaks: state of the art
I Cruz-Gonzalez, JC Rama-Merchan… - Netherlands Heart …, 2017 - Springer
Paravalvular leak (PVL) is a serious complication after surgical valve replacement or after
transcatheter aortic valve replacement. Approximately 1–5% of PVLs can lead to serious …
transcatheter aortic valve replacement. Approximately 1–5% of PVLs can lead to serious …
Percutaneous paravalvular leak closure: chasing the chameleon
F Nietlispach, F Maisano, P Sorajja… - European heart …, 2016 - academic.oup.com
Paravalvular leak (PVL) occurs after both surgical and transcatheter valve replacement/
implantation. It can lead to haemolysis, heart failure and may increase the risk of …
implantation. It can lead to haemolysis, heart failure and may increase the risk of …
[HTML][HTML] Transcatheter closure of paravalvular leak: Multicenter experience and follow-up
K Kalogeras, K Ntalekou, K Aggeli, C Moldovan… - Hellenic Journal of …, 2021 - Elsevier
Background Paravalvular leak (PVL) is a common complication following valve replacement,
which leads to heart failure and hemolysis. Transcatheter PVL closure has emerged as a …
which leads to heart failure and hemolysis. Transcatheter PVL closure has emerged as a …
[HTML][HTML] Catheter-based treatment of paravalvular leaks
M Taramasso, F Maisano, A Pozzoli… - …, 2016 - eurointervention.pcronline.com
The incidence of paravalvular leaks after surgical valve replacement is estimated to be 2-
17%. Paravalvular leaks (PVL) can be asymptomatic and not require treatment or can cause …
17%. Paravalvular leaks (PVL) can be asymptomatic and not require treatment or can cause …
Predictors of clinical success after transcatheter paravalvular leak closure: an international prospective multicenter registry
Background: Transcatheter closure of a symptomatic prosthetic paravalvular leak (PVL) is
feasible, but there is presently no conclusive evidence to show consistent efficacy. We …
feasible, but there is presently no conclusive evidence to show consistent efficacy. We …